Tag - pfizer

 
Menu
Search
 
November 24, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PFIZER

Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer's COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer's bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
WORLD / Science & Health
Nov 7, 2022
Pfizer’s Paxlovid anti-viral seen to lower long-COVID risk in study
Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering post-viral complications, researchers found.
Japan Times
WORLD / Science & Health
Nov 5, 2022
Study shows new booster improves protection for older people, Pfizer says
U.S. officials are hoping that the encouraging results will improve what has so far been a dismal public response to the retooled shots.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer's omicron booster can be administered to people age 12 and over, while Moderna's is limited to those 18 and above, the panel advised.
Japan Times
JAPAN / Science & Health / EXPLAINER
Aug 12, 2022
What we know about the new omicron vaccines
New vaccines developed for the COVID-19 omicron variant are scheduled to be available from mid-October in Japan, raising hopes that the population will soon be better protected.
Japan Times
BUSINESS / Companies
Aug 9, 2022
Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
Pfizer will gain Oxbryta, South San Francisco-based Global Blood's therapy for sickle-cell disease that sold about $195 million last year.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
ASIA PACIFIC / Science & Health
Apr 4, 2022
China promotes traditional cures as Pfizer pill alternatives
China is struggling to persuade skeptics to put aside doubts about traditional medicine that hasn't gone through large, standardized clinical trials.
Japan Times
WORLD / Science & Health
Mar 27, 2022
Second vaccine booster significantly lowers COVID-19 death rate: Israeli study
Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
JAPAN / Science & Health
Feb 16, 2022
Despite ministry recommendation, some parents in Japan wary of COVID jabs for children
Vaccinations for children ages 5 to 11 could start by the end of February, with the government recommending all children receive a shot, particularly those with underlying conditions.
Japan Times
ASIA PACIFIC
Feb 15, 2022
China’s approval of Pfizer pill opens door to ending 'COVID zero'
Having an effective anti-viral in its arsenal could help China mitigate the lower efficacy of its homegrown vaccines if the virus was allowed to circulate more freely.
Japan Times
JAPAN / Science & Health
Feb 10, 2022
Japanese health ministry approves Pfizer's COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms.
Japan Times
JAPAN
Feb 7, 2022
Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD
Jan 26, 2022
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine
The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
U.S. aircraft carrier returns to Japan carrying navy’s ‘most capable fighter’
U.S. 7th Fleet Commander Vice Adm. Fred Kacher speaks to reporters shortly after the arrival of aircraft carrier USS George Washington at Yokosuka naval base in Kanagawa Prefecture on Friday.
After Shohei Ohtani bump, Iwate ironware maker sees brighter future
Kaito Kikuchi's decision to send superstar Shohei Ohtani one of his company's traditional ironware tea kettles has paid off with a surge of interest from general consumers.
Japan approves ¥21.9 trillion stimulus plan
The policy chiefs of the Democratic Party for the People, Liberal Democratic Party and Komeito — Makoto Hamaguchi (left), Itsunori Onodera (center) and Mitsunari Okamoto — shake hands after reaching an agreement on an economic stimulus package on Wednesday.
Woman dies after train collides with car in Tochigi
A Moka Railway train car
Japan will spend ¥325 million in government funds on Princess Yuriko's funeral
Princess Yuriko waves during the New Year's public greeting at the Imperial Palace in Tokyo in January 2019.
133-year-old Kyushu railway station remains to be partially preserved
The remains of the original Moji Station in Kitakyushu
After Shohei Ohtani bump, Iwate ironware maker sees brighter future
Kaito Kikuchi's decision to send superstar Shohei Ohtani one of his company's traditional ironware tea kettles has paid off with a surge of interest from general consumers.
Shohei Ohtani wins National League MVP award
Shohei Ohtani celebrates after hitting a three-run home run against the Padres during the National League Division Series at Dodger Stadium in Los Angeles last month.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”
Around a quarter of Japan married couples in their 20s met through dating apps
A survey released by an organization promoting “Good Couples Day” shows that 24% of couples in their 20s met their marriage partner through a dating app.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world
mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in the world

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER